A High-Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury

Maria Kost-Alimova, Eriene Heidi Sidhom, Abhigyan Satyam, Brian T. Chamberlain, Moran Dvela-Levitt, Michelle Melanson, Seth L. Alper, Jean Santos, Juan Gutierrez, Ayshwarya Subramanian, Patrick J. Byrne, Elizabeth Grinkevich, Estefanía Reyes-Bricio, Choah Kim, Abbe R. Clark, Andrew J.B. Watts, Rebecca Thompson, Jamie Marshall, Juan Lorenzo Pablo, Juliana CoraorJulie Roignot, Katherine A. Vernon, Keith Keller, Alissa Campbell, Maheswarareddy Emani, Matthew Racette, Silvana Bazua-Valenti, Valeria Padovano, Astrid Weins, Stephen P. McAdoo, Frederick W.K. Tam, Luciene Ronco, Florence Wagner, George C. Tsokos, Jillian L. Shaw, Anna Greka

Research output: Contribution to journalArticlepeer-review

34 Scopus citations

Fingerprint

Dive into the research topics of 'A High-Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases